Annals of Noninvasive Electrocardiology (Jan 2022)

QTc interval prolongation in the patients with primary biliary cholangitis

  • Zihao Wang,
  • Rongkai Qian,
  • Yanhua Wang,
  • Lingfei Mo,
  • Bomiao Ju,
  • Nan Hu,
  • Pei Wang,
  • Lan He,
  • Jing Wang

DOI
https://doi.org/10.1111/anec.12925
Journal volume & issue
Vol. 27, no. 1
pp. n/a – n/a

Abstract

Read online

Abstract Background The QT interval prolongation was associated with fatal arrhythmias and cardiac death. However, there were not adequate data to clarify the situation of QT interval prolongation in primary biliary cholangitis (PBC) patients. The aim of this study was to clarify the rate and the associated risk factors of corrected QT (QTc) interval prolongation in PBC patients. Methods From January 2016 to December 2020, PBC patients were retrospectively enrolled. The rate of QTc interval prolongation was surveyed and the associated risk factors were clarified by univariate and multivariate analyses. Results Among the 189 PBC patients, 24.3% (46/189) had the QTc interval prolongation. The univariate analysis showed that age, Child‐Pugh classification, creatinine, international normalized ratio (INR), and platelet (PLT) were associated with QTc interval prolongation in the PBC patients. The multivariate analysis further showed only age (p = .028) and Child‐Pugh classification (p = .035) were the associated risk factors. It had the highest risk of QTc interval prolongation (as high as 64.3%) in the patients who were more than 62.5 years old and with Child‐Pugh C. Conclusion The QTc interval prolongation was frequent in PBC patients, especially in the patients with decompensated cirrhosis. The rate of QTc interval prolongation was as high as 64.3% in the PBC patients who were more than 62.5 years old and classified as Child‐Pugh C.

Keywords